Laboratory and testing services

Ended Purchase Order Awarded Last action

Contract number
75N91021P00321
Awardee
Awarding agency
Obligated
$16,800

Award facts

Contract value 100% obligated
$16,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Renton, WA 98059, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Talus Bioscience Inc. for $16,800.00 in laboratory and testing services, effective April 27, 2021, with an ultimate completion date of May 27, 2021. Work is performed in Renton, Washington. The order carries firm fixed price terms and is not set-aside.

Quick answers

Who was awarded contract 75N91021P00321?

75N91021P00321 was awarded to Talus Bioscience Inc. by National Cancer Institute (National Institutes of Health) on April 27, 2021.

How much is contract 75N91021P00321 worth?

The government has obligated $16,800 on 75N91021P00321.

Was contract 75N91021P00321 competed?

The extent of competition for 75N91021P00321 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award